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Abstract
Background: Osteopontin (OPN) is a plasma protein/cytokine produced in excess in several malignancies. In a
recent study OPN was reported as being related to the duration of asbestos exposure and presence of benign
asbestos-related diseases; however, it was unclear whether this protein was an indicator of exposure or effect.
Methods: In 193 workers, 50 with pleural plaques (PP), in whom different indicators of past asbestos exposure
were estimated, OPN plasma levels were assessed using commercial quantitative sandwich enzyme immunoassays
according to the manufacturer’s instructions.
Results: Osteopontin increased with increasing age and several aspects of asbestos exposure, without differences
related to the presence of pleural plaques. At multivariable regression analysis, the explanatory variables with a
significant independent influence on OPN were length of exposure (positive correlation) and time elapsed since
last exposure (positive correlation).
Conclusions: Since asbestos in lung tissue tends to wane over time, OPN should decrease (rather than increase)
with time since last exposure. Therefore, OPN cannot be a reliable biomarker of exposure nor effect (presence of
pleural plaques).
Background
In the absence of quantitative exposure data, asbestos
exposure could be retrospectively evaluated. According
to the job-exposure matrix (JEM) approach, the workers
are divided into homogeneous groups, based on combi-
nations of plant, work area, job title, historical period;
the available industrial hygiene measurement series are
then related to the same groups. The main limitations
of this approach are that: (i) trends over time are often
unknown; and (ii) the inter-individual variations within
“homogeneous” groups - i.e.: same job title - can some-
times be more relevant than those between groups [1].
In the job-specific modules (JSM) approach, the most
significant factors capable of affecting the exposure
intensity are first identified; their relative importance is
then assessed, based on the available industrial hygiene
historical data, or the engineering evaluation of tasks/
operations, or both of them. The main limitations of the
JSM approach are: (i) the relative importance of the var-
ious determinants may prove difficult to be assessed; (ii)
concordance among experts about this item may be
poor; (iii) the quality of the available information about
the determinant(s) may vary among the study subjects,
so that for someone all the details of the tasks involved
by their job may be carefully described, while for some-
one else the job title is barely known [1].
Osteopontin (OPN) is a plasma protein/cytokine that
is produced in excess in malignant mesothelioma and
cancer of the lung, breast, colorectal, stomach, and
ovary [2-4]. Pass [5] reported that OPN was related to
the duration of asbestos exposure and presence of
benign asbestos-related diseases. However, workers with
pleural plaques and asbestosis also had a longer dura-
tion of exposure; it was therefore unclear whether OPN
was an indicator of exposure or effect. With the aim of
testing a new procedure possibly useful in surveillance
of past asbestos workers, the present investigation
assesses the relationship between plasma OPN levels
and asbestos exposure or the presence of pleural plaques
(PP), in asbestos workers formerly examined within the
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Methods
Study population
904 workers previously exposed to asbestos - already
examined at the Occupational Health Service (OHS) of
the Primary Care Trust (PCT) 12, Venice, Veneto
Region (Italy) - were stratified by cumulative exposure
and PP and 30% of them were extracted from each stra-
tum with a random sampling procedure. The final sam-
ple included 263 subjects, 54 with and 209 without PP.
These subjects received a letter of invitation and respon-
dents were phoned one or two weeks later to fix an
appointment for a medical examination. One hundred
and ninety two out of 263 workers (73%) agreed to be
examined. Since the original number of subjects with PP
was only 54, in order to avoid small numbers, 8 addi-
tional newly examined workers with PP were included
in the study, totalling 200 examined subjects.
After providing written informed consent, subjects
were examined by occupational physicians, using the
same protocol for collecting clinical and occupational
histories and taking blood samples. Incidental findings
were discussed with the patients and their primary care
physicians and, where appropriate, referred for specialist
evaluation. Information on smoking habits was collected
and smoking cessation was recommended and facilitated
for all patients.
Ethical Considerations
Approval by the local ethics committee was not required
since the medical surveillance of workers formerly
exposed to asbestos was a mandatory activity (Veneto
Region Decree Law n. 5094, Dec 28
th 1998; and Veneto
Region Directorate Decree No. 48 of 20/12/2006, that
included collection of blood samples in the protocol of
medical surveillance).
Assessment of historical asbestos exposure
We used an internationally established questionnaire
that allows the estimation of past asbestos exposure
using JSM [1]. On the basis of defined scales, examiners
scored the determinants of exposure: raw materials used
(with fibre content and friability); jobs undertaken (spe-
cified in terms of mechanical disturbance applied to
materials through the tools used by the worker); and
factors modulating exposure (particle emission speed,
source surface, presence of localized air exhaust systems,
dimension and physical characteristics of the rooms,
etc.). Through direct knowledge or literature data
describing historical exposure levels in different jobs/
tasks, a reference database was separately collected.
Using this a priori knowledge, or integrating evaluation
from all of the above scores, an exposure intensity was
attributed. Lastly, a semi-quantitative estimate of cumu-
lative exposure was made by multiplying intensity (con-
centration), frequency (percent of the working time
spent at a certain exposure level) and length of exposure
in years, and by summing up as many products as were
necessary to take into account the different jobs under-
taken. The interviewers were trained in the use of the
questionnaire in order to minimize the information bias.
Plasma samples and Osteopontin ELISA assay
Blood samples (12 ml) were collected by forearm veni-
puncture in BD Vacutainer sterile tubes containing K2-
EDTA and processed within maximum 2 hours. The
blood was centrifuged at 1,500 g for 20 minutes at room
temperature. Plasma was then collected, aliquoted in
sterile Safe Lock tubes, and stored at -25°C until further
analysis. Repeated freezing and thawing cycles were
avoided.
Plasma OPN was analyzed using an Osteopontin
TiterZyme ELISA kit (Assay Designs, Ann Arbor, MI)
according to the manufacturer’s instructions and results
were expressed in ng/ml. All samples were coded for a
blinded analysis, and each plasma was determined in
duplicate. Quality controls were analyzed in every plate.
The analytical validity of the assay was also indepen-
dently confirmed, and optimal results in terms of sensi-
tivity, precision and recovery were obtained. The intra-
assay precision was 6.5% at 24 ng/ml and 3% at 56.7 ng/
ml, with analytical sensitivity of 1.78 ng/ml. Moreover,
test of linearity (four dilutions from 1:2 to 1:16) and
recovery from spiked samples gave acceptable results
(mean recovery: 102% and 95.5%, respectively). All
assays were carried out in a single session in the same
laboratory (Regional Centre for the Study of Biological
Markers of Malignancy, PCT 12, Venice, Veneto Region,
Italy).
Statistical analysis
The mean, standard deviation (SD), median, 25% and
75% percentiles, and the results of Shapiro-Wilk test for
normality were calculated in two groups of subjects
(with or without PP) for OPN, age, time elapsed since
first exposure (TSFE), time elapsed since last exposure
(TSLE), length of exposure, peak asbestos level (highest
asbestos exposure for any job held), and cumulative
asbestos exposure. The two groups were then compared
by calculating the non-parametric Wilcoxon rank-sum
test statistics and the corresponding p-values.
Smoking was coded in three classes: non-smokers, ex-
smokers (those who had given up smoking for at least
one year), and current-smokers (if he/she regularly
smoked at least one cigarette per day or a pipe or one
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that added up to 12 months). The comparison of smok-
ing classes between the two groups (with or without PP)
was performed using the chi-square (c
2) test.
Several models of linear regression (and several bivari-
ate scatter diagrams) were built, separately in workers
with and without PP, where the dependent variable was
always OPN and the independent variable was age or
TSFE, TSLE, duration of asbestos exposure, peak expo-
sure, cumulative exposure, smoking classes. To test
whether the coefficient estimated over the group with-
out PP was equal to the coefficient estimated over the
group with PP, the Chow test statistics and the corre-
sponding p-values were calculated.
Data of both groups were pooled together and OPN
was regressed against age and asbestos exposure indices
at univariable and multivariable linear regression
analysis.
To convert OPN into a normally distributed variable,
the inverse transformation (1/x) was chosen because it
minimized the c
2 test for departure from normal distri-
bution. The normal distribution of the transformed vari-
able was then checked using a Q-Q plot (quantiles of 1/
OPN against the quantiles of the normal distribution), a
graph of kernel density estimates (Epanechnikov kernel
function) against normal density, and the Shapiro-Wilk
normality test.
At multivariable analysis, two models of linear regres-
sion were fitted where 1/OPN was the dependent vari-
able and the above indicators acted as predictors. In
Model 1, the associated risk factors were identified with
the backward stepwise selection of predictors using 0.05
as criterion. In Model 2, age was introduced into the
former model. In order to obtain more interpretable
results, other models of multivariable linear regression
were fitted where the dependent variable was OPN and
the predictors were the same as the above. Normality of
the residuals was checked using a Q-Q plot, a graph of
kernel density estimates, and the Shapiro-Wilk normal-
ity test.
According to Checkoway [8], the matrix of correlation
coefficients “r” (and the scatter plot matrix) between all
possible pairs of the independent variables was used to
estimate collinearity (linear relationship between two
predictors). Furthermore, when comparing a crude (uni-
variable regression) with an adjusted (multivariable
regression) estimate, the inflation of the standard error
of a regression coefficient was used to check on the
degree of multicollinearity (when more than two vari-
ables are involved), while the change in the regression
coefficient was used to evidence a confounding effect.
All statistical analyses were carried out with STATA
10 (Stata Corporation, College Station, Texas, USA).
Results
Seven subjects with missing values were discarded; the
analysis refers to 193 subjects, 50 with and 143 without
PP.
The key characteristics of subjects, categorized by PP,
are displayed in table 1. The distribution was not normal
for all variables except TSFE in workers without PP,
while it was normal for all variables except cumulative
exposure in workers with PP (Shapiro-Wilks test, data
not shown). The non parametric Wilcoxon rank-sum test
provided statistically significant differences between
groups for age, TSFE, cumulative and peak exposure, but
not for OPN, TSLE, and length of exposure. The median
of TSLE (14 in the first and 15.5 years in the second
group) was close to the time elapsed - 16 years - between
2008 (year of observation) and 1992 (ban of asbestos in
Italy). The workers in the first quartile of TSLE were
probably those employed in asbestos decontamination in
industry and housing after 1992. The top quartile of
TSLE included workers no longer exposed to asbestos
from at least 18 years. Although length of exposure was
quite long, most subjects were not in an advanced age.
The ban of asbestos in 1992 combined with a high length
of exposure resulted in high values of TSFE. It can be
seen that cumulative exposure in workers with PP largely
exceeded that of workers without PP. This difference
could be explained by a higher peak exposure, given that
length of exposure was fairly similar in both groups.
Non smokers, former smokers and current smokers
were, respectively, 29%, 60% and 10% in the group with-
out PP and 14%, 20% and 66% in workers with PP;
there was a borderline level of significance (p-value =
0.044) at the c
2 test.
In former and current smokers, respectively, starting
age of smoking was 16.9 (SD = 3.7) and 18.6 (SD = 5.1)
years, age at smoking cessation was 40.0 (SD = 10.9)
and 60.3 (SD = 6.1), number of cigarettes/day was 20.3
(SD = 13.5) and 14.1 (SD = 6.8), and the number of
pack-years was 23.1 [= (40.0-16.9) × (20/20)] and 29.2
[= (60.3-18.6) × (14/20)].
Table 2 and figure 1 and 2 show that the trend of
OPN over age or each aspect of exposure to asbestos
fibres (TSLE, TSFE, length, cumulative and peak expo-
sure) was not significantly different in relation to the
presence of PP. Since smoking and peak exposure are
not continuous variables, the regression coefficients
could be interpreted as a linear trend across ordered
categories.
Since they were not statistically different, data from
both groups were pooled together. Figure 3 shows that
age was strongly correlated with some exposure vari-
ables: TSFE (r = 0.77) and TSLE (r = 0.60). There was
therefore evidence of collinearity among predictors.
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error of the coefficient (SE(b)), and p-value of the z test
statistics provided by the linear regression analysis. At uni-
variable analysis, OPN was found to be associated with age
(positive correlation), TSLE and TSFE (positive correla-
tion), and cumulative exposure (positive correlation).
Since smoking and peak exposure were not continuous
variables, the regression coefficients could be interpreted
as linear trend across ordered categories. The results of
multivariable analysis (Model 1 and 2) are shown in the
same table 3. Only TSLE and length of exposure (positive
correlation) entered the multivariable model. It can be
seen that, for TSLE, SE(b) from simple regression (0.22)
was fairly similar with that of Model 1 (0.23) but different
from that of Model 2 (0.35). Likewise, for age, SE(b) was
0.21 at univariable analysis and 0.33 in the Model 2. The
inflation of SE(b) in the Model 2 demonstrated the pre-
sence of multicollinearity. The coefficient “b” for age was
0.94 in the simple regression and 0.19 in the Model 2,
revealing the presence of a strong confounding.
Table 4 is similar to table 3, with the difference that
the dependent variable was the reciprocal of OPN. It
can be seen that at univariable analysis, the sign of “b”
is always negative, revealing a negative correlation
between 1/OPN and exposure variables (thus confirming
the positive association between OPN and asbestos
exposure variable). Only TSFE entered the Model 1 of
multivariable analysis; it is worth noting that TSFE is
the sum of TSLE and length of exposure. The SE(b)
obtained at simple regression and Model 2 of multivari-
able analysis was, respectively, 5.50E-05 and 8.65E-5 for
TSFE; 6.00E-05 and 9.28E-5 for age. There was evidence
of multicollinearity, but not of strong confounding since
the regression coefficients did not change markedly.
Discussion
We aimed to assess an association between plasma levels of
OPN and, on the other hand, asbestos exposure or the pre-
sence of asbestos related benign diseases. This study sug-
gests that OPN is not a reliable marker for the presence of
Table 1 Mean and standard deviation (SD), median and quartiles (25-75 centiles) of the key characteristics and
p-value of the Wilcoxon rank-sum test comparing two groups, with or without pleural plaques (PP)
Key characteristics Without PP (N = 143) With PP (N = 50) p-value
Mean (SD) Median (25-75 centiles) Mean (SD) Median (25-75 centiles)
Osteopontin (ng/ml) 53.89 (19.57) 49.53 (42.50-57.64) 55.25 (20.86) 50.87 (40.78-66.22) 0.872
Age (years) 62.90 (6.40) 61.94 (58.12-67.37) 65.78 (6.05) 64.71 (61.86 -68.33) 0.005
Time since last exposure (years) 13.71 (6.69) 14 (8 -18) 15.36 (5.50) 15.5 (12-20) 0.067
Time since first exposure (years) 42.20 (6.92) 42 (37-47) 45.12 (6.38) 45 (40-50) 0.010
Length of exposure (years) 26.24 (6.97) 27 (22-30) 27.70 (5.67) 28 (25 - 29) 0.170
Cumulative exposure (ff/ml) × years 166.13 (120.2) 155.53 (44.79-299.2) 237.52 (102.3) 298.08 (155.5 -301.1) 0.001
Peak exposure (ff/ml) 56.49 (59.7) 13.5 (13.5-135) 88.32 (60.3) 135 (13.5 -135) 0.002
Table 2 Linear regression coefficients (b), standard error of the coefficient (SE(b)) and p-value of the Chow test
statistics, comparing two coefficients estimated over two groups, with or without pleural plaques (PP)
Predictor variables
§ Without PP (N = 143) With PP (N = 50) p-value
b SE(b) b SE(b)
Age (years) 0.93 0.25 1.05 0.47 0.88
Time since last exposure (years) 0.71 0.24 1.35 0.51 0.52
Time since first exposure (years) 0.94 0.22 1.23 0.44 0.74
Length of exposure (years) 0.45 0.23 - 0.03 0.53 0.95
Cumulative exposure (ff/ml) × years 0.04 0.01 0.01 0.03 0.48
Peak exposure (ff/ml) 0.05 0.03 -0.02 0.05 0.46
Smoking classes -1.67 2.72 1.16 5.14 0.50
§ The dependent variable is Osteopontin in all models of linear regression analysis.
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Page 4 of 8pleural plaques (table 12; and figure 12): if OPN were a
profibrotic mediator of some lung compartments [9], there
would be different levels in subjects with or without PP.
Likewise, a recent study [10] reported that the average level
of OPN in healthy subjects exposed to asbestos (n = 112)
was not significantly different from that in subjects with
benign asbestos disease (n = 33).
The present study also suggests that OPN is not a
reliable biomarker of the lung burden of asbestos since
an increasing relation was found between OPN and
TSLE (table 3). However, it is known that chrysotile dis-
s o l v e sf a i r l yr a p i d l yi nl u n gt i s s u e-t h eh a l f - l i f ei s
approximately six months and some papers suggest that
this time period may be even shorter [11-13]. Pulmon-
ary amphiboles are also removed but at a slower rate. It
has been calculated that in humans the elimination of
crocidolite fibres is 10 to 15% per year, which means
that every 7-10 years half of the contents of fibres accu-
mulated in the lung will be destroyed and/or expelled
[14]. Since the median TSLE was about 15 years (table
1), in about 50% of examined workers the lung burden
should be approximately zero for chrysotile and reduced
by more than half for amphiboles.
Age was found to be a strong confounder and a
source of multicollinearity (Model 2 in table 3 and 4)
since it was significantly and positively correlated with
OPN (tables 2, figure 1) and the time indicators of
asbestos exposure (figure 3). Deleting age from the
model (as in Model 1 of tables 3 and 4) greatly reduced
the standard error; but the increase in the precision of
estimate may be offset by an increase in bias due to
inadequate control of confounding [15].
According to Pass [5], serum OPN levels were signifi-
cantly (p < 0.02) higher in workers with more than 10
years as compared to those with 0-9 years of exposure.
Pass [5] also reported that in patients with “plaques and
fibrosis” serum OPN was significantly (p < 0.004) higher
than in subjects with normal or “other” radiographic find-
ings. Due to the similarity of the points shown in a graph
(figure 3 of the latter paper), workers with plaques and
fibrosis also had more than 10 years of asbestos exposure.
However, the present study envisages the possibility that
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Figure 1 Scatter plot of Osteopontin (OPN) versus age, time elapsed since first exposure (TSFE), time elapsed since last exposure
(TSLE) and length of exposure, in workers with and without Pleural Plaques (PP), separately.
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founding by age or have arisen by chance.
One could ask if there is any reason for assessing OPN
levels only in plasma and not in serum. The reason is
related to evidence that differences between serum and
plasma samples exist for measurement of OPN. OPN pre-
sent in whole blood is cleaved in the course of blood coa-
gulation and cleavage by thrombin can produce OPN
fragments that have biological activity different from the
whole protein [16]. Therefore, it is not recommended to
use serum or heparin plasma in the OPN assay as this pro-
tein is likely to be cleaved in these matrices. Moreover,
plasma was the preferred clinical specimen for measure-
ment of OPN in studies for diagnosis of epithelial malig-
nant pleural mesothelioma because OPN serum levels
were influenced by pre-analytical factors like as thawing
[17]. Lastly, other than the choice of material, e.g. plasma
vs. serum, the duration of storage may also affect the
results of the OPN measurement by ELISA [18].
In our population the median OPN plasma level was
49.9 ng/ml, whereas a previous study has shown OPN
plasma levels of 28.3 ng/ml in subjects with non-malig-
nant pulmonary diseases [19]. The discrepancy could be
attributed to the different OPN ELISA commercial kits
used in the two studies (Assay Designs and R&D Sys-
tems, respectively). A systemic bias was also found
between human osteopontin ELISA commercial kits
supplied by different manufactures (Immuno-Biological
Laboratories Co., Ltd, Gunma, Japan vs R&D systems,
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Figure 2 Scatter plot of Osteopontin (OPN) versus cumulative exposure, peak exposure and classes of smoking, in workers with and
without Pleural Plaques (PP), separately.
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Figure 3 Scatterplot matrix of the independent variables: age;
time since last exposure (tsle); time since first exposure (tsfe);
length of exposure; and cumulative exposure. Simple correlation
coefficient (r) in every plot.
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Page 6 of 8Minneapolis, MN, USA), with lower concentrations
measured by R&D systems assay [20]. Moreover, a
review of the literature suggests that different commer-
cially available OPN ELISA systems produce different
absolute plasma OPN levels and that even with identical
ELISA systems plasma OPN levels measured can only
be compared with caution [18].
Some limitations of the study must also be discussed.
The first limitation of the study is the lack of cases of
asbestosis. Another limitation comes from the fact that,
since PP cases were relatively few, 8 subjects with PP not
present in the original list and lately addressed to the OHS
were added to the sample. This fact may have limited the
representativeness of the sample. However, the issue with
this study was analytical (is OPN associated to asbestos
exposure or to the most common benign asbestos disease
- PP?) rather than descriptive (which is the distribution of
OPN levels in the source population); only in the latter
event the sample should be strictly representative of the
large base population. A third limitation is the lack of an
objective measure of asbestos concentrations over time.
The past exposure was estimated retrospectively, generally
using the JSM approach. However, in 772 asbestos work-
ers examined with computed tomography, past exposure
(estimated with the above method) was strongly related
with the risk of benign asbestos disease (p trend <0.001),
demonstrating that the assessment of the historical asbes-
tos exposure was valid [7].
Conclusions
Plasma Osteopontin cannot be used as surrogate of
asbestos exposure and does not differentiate asbestos
workers with or without pleural plaques. Therefore, in
the absence of actual exposure measurements, the best
method for determining historical exposure to asbestos
is the JSM or JEM approach.
Table 3 Linear regression coefficient (b), standard error of the coefficient (SE(b)) and p-value of the z test statistics at
univariable and in two models of multivariable regression
Predictor variables
§ Univariable analysis Multivariable analysis
Model 1
@ Model 2
#
b SE(b) p-value b SE(b) p-value b SE(b) p-value
Age (years) 0.94 0.21 0.000 0.19 0.33 0.570
Time since last exposure (years) 0.83 0.22 0.000 1.13 0.23 0.000 0.98 0.35 0.005
Time since first exposure (years) 0.99 0.20 0.000
Length of exposure (years) 0.37 0.21 0.090 0.77 0.22 0.000 0.68 0.27 0.014
Cumulative exposure (ff/ml) × years 0.03 0.01 0.009
Peak exposure (ff/ml) 0.03 0.02 0.150
Smoking classes - 0.77 2.36 0.746
§ The dependent variable is Osteopontin in all models of linear regression analysis.
@ Estimated with forward stepwise selection of predictors.
# Estimated forcing age in the model 1.
Table 4 Linear regression coefficient (b), standard error of the coefficient (SE(b)) and p-value of the z test statistics at
univariable and in two models of multivariable regression: (1) estimated with forward stepwise selection of predictors;
and (2) estimated forcing age in the former model
Predictor variables
§ Univariable analysis Multivariable analysis
Model 1
@ Model 2
#
b SE(b) p-value b SE(b) p-value b SE(b) p-value
Age (years) -1.95E-4 6.00E-5 0.001 1.41E-5 9.28E-5 0.879
Time since last exposure (years) -2.28E-4 5.90E-5 0.000
Time since first exposure (years) -2.42E-4 5.50E-5 0.000 -2.42E-4 5.47E-5 0.000 -2.5E-4 8.65E-5 0.004
Length of exposure (years) -1.06E-5 5.90E-5 0.858
Cumulative exposure (ff/ml) × years -7.87E-6 3.25E-6 0.016
Peak exposure (ff/ml) -1.09E-5 6.41E-6 0.089
Smoking classes -2.79E-4 6.50E-4 0.668
§ The dependent variable is Osteopontin in all models of linear regression analysis.
@ Estimated with forward stepwise selection of predictors.
# Estimated forcing age in the model 1.
The dependent variable is 1/Osteopontin in all models of linear regression analysis.
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